BioSpace News Archive

Ocular Therapeutix™, Inc. announced that the Centers for Medicare and Medicaid Services has approved transitional pass-through payment status and established a new reimbursement code for DEXTENZA®.

InVivo Therapeutics Holdings Corp. announced that the first two patients have been enrolled into The INSPIRE 2.0 Study.

Steps to Combatting the Country’s Opioid Crisis Identified: Risk Assessments, Prevention Protocols, Outcome Reporting, and Education

JLK Inspection, a company specializing in world-class AI-based medical imaging solutions and a company of the Born2Global Centre, has developed JPC-01K, an AI-based prostate MR image analysis solution, and JBS-01K, which is used for quantitative analysis of brain MR images, and recently obtained European CE certification for such products, in accordance with the European Medical Device Directive.

OncoSec Medical Incorporated and Emerge Health Pty have entered into a collaboration agreement commercializing OncoSec’s proprietary TAVO and making it available under Australia’s Special Access Scheme in 2019.

Advent of the Soft Exo-Suit Generation expands assistive robotic therapy for stroke survivors

LifeSprout, a privately-held aesthetics and regenerative medicine company founded out of Johns Hopkins University, announced that it has closed a $6.5 million seed-stage financing.

Company invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation on VirtualInvestorConferences.com

Co-founder and CEO Fabio Gratton Recognized with PM360 ELITE 2019 Data Miner Award for Redefining Listening in Market Research [29-May-2019] PHILADELPHIA , May 29, 2019 /PRNewswire/ -- inVibe Labs , a market research innovator dedicated to changing the way healthcare organizations listen to their customers, helps healthcare companies better understand the thoughts an

The Michigan Mesothelioma Victims Center says we are urging a US Navy Veteran or a factory worker anywhere in Michigan with recently diagnosed mesothelioma to call us anytime at 800-714-0303.